中/EN Contact/Message
  • Home
  • central pharmacy
  • Policies
  • Medical Institution
  • Franchise
  • Innovate
  • Recruit
  • News
  • Home
  • central pharmacy
  • Policies
  • Medical Institution
  • Franchise
  • Innovate
  • Recruit
  • News
  • 中/EN
  • Contact/Message
    • Innovate
    Your current position：
    Vonjo
    Vonjo
    departments：内科
    drug：胶囊
    Active：pacritinib
    indication：治疗低血小板成人的中高风险原发性或继发性骨髓纤维化
    Licensor：CTI BioPharma
    Approved Country/Region：FDA
    Approval time：2022-02-28